Chemoinformaics analysis of CYANIDIN-3-RHAMNOSYLGLUCOSIDE
| Molecular Weight | 164.157 | nRot | 4 |
| Heavy Atom Molecular Weight | 152.061 | nRig | 1 |
| Exact Molecular Weight | 164.068 | nRing | 0 |
| Solubility: LogS | -0.015 | nHRing | 0 |
| Solubility: LogP | -2.017 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 22.0315 |
| nHD | 4 | BPOL | 12.9065 |
| QED | 0.373 |
| Synth | 3.54 |
| Natural Product Likeliness | 1.515 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.228 |
| HIA | 0.053 |
| CACO-2 | -5.135 |
| MDCK | 0.00268708 |
| BBB | 0.749 |
| PPB | 0.132676 |
| VDSS | 0.601 |
| FU | 0.760558 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.059 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.076 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.139 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.019 |
| CL | 2.139 |
| T12 | 0.845 |
| hERG | 0.07 |
| Ames | 0.053 |
| ROA | 0.013 |
| SkinSen | 0.057 |
| Carcinogencity | 0.015 |
| EI | 0.079 |
| Respiratory | 0.012 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.926511 |